Experts from Wiley discuss a strategy-driven approach to Medical Education, powered by timely, credible information delivered in multiple formats.
This series of the Elevate Podcast illuminates how AI and Generative AI seem to be a part of every webinar, conference, and conversation these days. This podcast will explore three proof-of-concept (POC) use cases from recent work in the field of Medical Information.
This article explores key questions on how Medical Affairs teams manage patient engagement across different-sized companies who have variations in focus, resources, and scale.
Regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Consequently, Pharma companies are increasingly including real-world studies in their evidence to:
• Understand the opportunities and best practices for involving patient partners in the generation of real-world evidence
• Explore, using case studies, the value of patient engagement in the design, delivery, analysis and communication of real-world studies
• Highlight the importance of Medical Affairs and Health Economics and Outcomes Research (HEOR) professionals in partnering with colleagues from different functions in Pharma to ensure patients are effectively engaged throughout the product lifecycle
• Discuss barriers and propose solutions to optimal patient engagement in real-world studies
What makes a publication interesting or impactful? Is it number of citations? Sentiment among important stakeholders? Relevance to the largest patient population? Popular news attention? The answer depends on your strategy. Here we speak with experts from Altmetric about 10 publications that are impactful for different reasons.
The Medical Affairs Professional Society (MAPS) is pleased to share our 2024 Digital, Advanced Analytics and Artificial Intelligence (AI) in Medical Affairs report. This report is based on findings from 32 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors, and reflects broad leadership thinking about the current and future states of Medical Affairs (MA) AI capability and challenges.
Survey design and analysis: Boston Consulting Group led the preparation, execution and analyses of the GenAI survey and moderated the Ambassador GenAI and Advanced Analytics workshop during the MAPS conference on March 24th, 2024.
Survey respondents: 34 representatives from 32 companies responded to our survey.
Participating companies: Thank you to participants from 3M, Abbott, AbbVie, Amgen, Astellas, AstraZeneca, Baxter, Bayer, bioMérieux, BioNTech, BMS, Eisai, Lilly, Gilead, Ipsen, Jazz Pharmaceuticals, Kyowa Kirin, Lundbeck, Mallinckrodt, Merck & Co, Mundipharma, Novartis, Otsuka, Regeneron, Sanofi, Sumitomo Pharma, Takeda, Teva, UCB, Varian, Vertex, and Viatris for your valuable feedback and insights.
The opinions expressed here are those of members of the MAPS Ambassador Alliance and do not necessarily represent the perspectives of their respective companies.
Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.
In this discussion, you’ll learn:
This series of the Elevate Podcast illuminates the Inspiration and Impact, content Compliance & Approval, MSL utilization, Training & Evolution, the Technology Stack, and the Future of Modular Content.
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we discuss the benefits of taking an analytical approach.
The objective is to illustrate how the strategic incorporation of interactive tools, visualization, and personalization of content can elevate the communication of medical and scientific information making it more accessible, engaging, and meaningful for diverse audiences. By embracing the innovative techniques from journalism, Medical Affairs professionals can build stronger communications with their audience, allowing for audiences to determine what they choose to view, in what order, and to the level of complexity they prefer. The presentation aims to be a facilitator for innovation, inspiring Medical Affairs professionals to adopt and adapt journalistic interactivity and visualization to their communication strategies.